Muc5b is required for airway defence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Respiratory surfaces are exposed to billions of particulates and pathogens daily. A protective mucus barrier traps and eliminates them through mucociliary clearance (MCC). However, excessive mucus contributes to transient respiratory infections and to the pathogenesis of numerous respiratory diseases. MUC5AC and MUC5B are evolutionarily conserved genes that encode structurally related mucin glycoproteins, the principal macromolecules in airway mucus. Genetic variants are linked to diverse lung diseases, but specific roles for MUC5AC and MUC5B in MCC, and the lasting effects of their inhibition, are unknown. Here we show that mouse Muc5b (but not Muc5ac) is required for MCC, for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in mouse lungs, whereas Muc5ac is dispensable. Muc5b deficiency caused materials to accumulate in upper and lower airways. This defect led to chronic infection by multiple bacterial species, including Staphylococcus aureus, and to inflammation that failed to resolve normally. Apoptotic macrophages accumulated, phagocytosis was impaired, and interleukin-23 (IL-23) production was reduced in Muc5b(-/-) mice. By contrast, in mice that transgenically overexpress Muc5b, macrophage functions improved. Existing dogma defines mucous phenotypes in asthma and chronic obstructive pulmonary disease (COPD) as driven by increased MUC5AC, with MUC5B levels either unaffected or increased in expectorated sputum. However, in many patients, MUC5B production at airway surfaces decreases by as much as 90%. By distinguishing a specific role for Muc5b in MCC, and by determining its impact on bacterial infections and inflammation in mice, our results provide a refined framework for designing targeted therapies to control mucin secretion and restore MCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as evidenced by the decrease in antibacterial cytokines and the presence of phagocytosis-impaired macrophages in the lungs of mucin-deficient mice133.”
From The microbiota of the respiratory tract: gatekeeper to respiratory health (2017) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Webb, A. K. (2006) · Cited by 4,369
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Self-citationAirway Mucus Function and Dysfunction
Fahy, J. V., & Dickey, B. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0910061 · Cited by 1,722
Self-citationAn efficient recombination system for chromosome engineering in Escherichia coli
Yu, D., Ellis, H. M., Lee, E.-C., Jenkins, N. A., Copeland, N. G., & Court, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127597 · Cited by 1,688
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Rowe, S. M., Miller, S., & Sorscher, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043184 · Cited by 1,398
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., Fingerlin, T. E., Zhang, W., Gudmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,198
Self-citation
Cited by
Items 501–600 of 767
García-Carmona, S., Falfán‐Valencia, R., Verónica-Aguilar, A., Buendía-Roldán, I., Chávez‐Galán, L., Hernández-Zenteno, R. D. J., Martínez-Morales, A., Fricke-Galindo, I., Alanis-Ponce, J., Rea, D. V.-P., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44080226 · Cited by 7
“This mechanism can remove pathogens and particles trapped in mucus, preventing them from accumulating in the upper and lower respiratory tract [22].”
BackgroundAlipio, H. R. D., Albaladejo-Riad, N., & Lazado, C. C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1083672 · Cited by 7
“The two muc5 genes, muc5ac and muc5b, play an essential role in airway defence in human and mouse, particularly in producingmucin glycoproteins that protect the respiratory surfaces from infections (Roy et al., 2014).”
BackgroundGenomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review
Ding, D., Gao, R., Xue, Q., Luan, R., & Yang, J. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.80358 · Cited by 8
“In 2011, two laboratories simultaneously reported that the MUC5B promoter variant rs3570 5950 is the strongest risk factor for the development of f-IPF and s-IPF (128) and appears to be similarly prevalent in patients with f-IPF and s-IPF (117) (approximately 50–60% of individuals with FIP or IPF).”
BackgroundLuo, W., Gu, Y., Fu, S., Wang, J., Zhang, J., & Wang, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115762 · Cited by 7
CD34 Differentially Regulates Contractile and Noncontractile Elements of Airway Reactivity
Lortie, K., Maheux, C., Gendron, D., Langlois, A., Beaulieu, M., Marsolais, D., Bossé, Y., & Blanchet, M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0008oc · Cited by 7
Hydrogen sulfide donor NaHS causes bronchitis with enhanced respiratory secretion in rats
Unuma, K., Aki, T., Yamashita, A., Yoshikawa, A., & Uemura, K. (2019) · The Journal of Toxicological Sciences · doi:10.2131/jts.44.107 · Cited by 7
La BPCO : une maladie qui commence précocement
Margelidon-Cozzolino, V., Chbini, K., Freymond, N., Devouassoux, G., Belaaouaj, A., & Pachéco, Y. (2015) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2015.08.002 · Cited by 9
“Ceci semble être confirmé par une tude récente [59] s’intéressant à l’altération des protéines omposant le mucus chez la souris, notamment les conséuences d’une disparition de la protéine Muc5b chez des ouris knock-out pour le gène codant cette protéine, qui rovoquent semble-t-il une inflammation bronchique et une mer…”
Ground zero—the airway epithelium
Reid, A. T., Sutanto, E. N., Veerati, P. C., Looi, K., Li, N. F., Iosifidis, T., Loo, S.-L., Garratt, L. W., & Kicic, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816417-4.00003-2 · Cited by 11
He, Z., Chu, C., Dickson, R. C., Okuda, K., & Cai, L. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00153.2023 · Cited by 11
ACKR3 in olfactory glia cells shapes the immune defense of the olfactory mucosa
Dietz, A., Senf, K., & Neuhaus, E. M. (2024) · Glia · doi:10.1002/glia.24527 · Cited by 6
“In the airways, Muc5b deficiency caused chronic infections by multiple bacterial species and inflammation, whereas Muc5b overexpression enhanced macrophage activation and elimination of bacteria (Livraghi-Butrico et al., 2017; Roy et al., 2014).”
BackgroundZhang, Y., Yu, Y., Xue, J., Yu, W., Zhou, X., Jin, M., Liu, P., Wang, T., Gao, Z., & Cuiling, F. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119831 · Cited by 6
Mucins and Their Roles in Asthma
Ye, Q., Opoku, G., Orlov, M., Jaramillo, A. M., Holguin, F., Vladar, E. K., Janssen, W. J., & Evans, C. M. (2025) · Immunological Reviews · doi:10.1111/imr.70034 · Cited by 11
Self-citationGenetics of interstitial lung diseases: a state-of-the-art review
Ng, N., Molina‐Molina, M., Adegunsoye, A., Borie, R., Newton, C. A., Raby, B. A., Zhang, D., Padilla, M. L., Crestani, B., Horwitz, M. S., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.00788-2025 · Cited by 9
Choi, Y. S., Na, H. G., Bae, C. H., Song, S., & Kim, Y. (2022) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2022.00857 · Cited by 6
“278 Among airway mucins, MUC5AC is known as a marker of goblet cell metaplasia, traditionally 279 associated with inflammatory conditions of the epithelium of sinonasal mucosa [21,22], so 280 clarification of the mechanisms that down-regulating overexpression of MUC5AC is essential for 281 identifying treatment strate…”
BackgroundHe, L., Feng, Q., Zhang, Q., Zhang, B., Wu, S., & Gong, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26094 · Cited by 6
“MUC5B mice develop severely impaired mucociliary clearance (MCC) and chronic bacterial infections with obstruction to airflow and inflammation of the airways.(2) In contrast, the role of MUC5AC is relatively modest.”
BackgroundType IV collagen reduces MUC5AC secretion in the lungs of ovalbumin-sensitized mice
Iwashita, J., Maeda, H., Ishimura, M., & Murata, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.851374 · Cited by 6
“MUC5B is produced in the normal respiratory tract and is important for biological defense (Roy et al., 2014).”
BackgroundFrontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19
Hastak, P., Andersen, C., Kelleher, A. D., & Sasson, S. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983550 · Cited by 6
“MUC5B expression has been associated with inflammation and phagocytotic response in the lungs (38).”
BackgroundAnti-fibrotic strategies and pulmonary fibrosis
Gunatilaka, A., Zhang, S., Tan, W. S. D., & Stewart, A. G. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.04.002 · Cited by 7
Mathai, S. K., & Schwartz, D. A. (2015) · European Respiratory Journal · doi:10.1183/09031936.00052715 · Cited by 7
Self-citationBasic Science Concepts in Otitis Media Pathophysiology and Immunity: Role of Mucins and Inflammation
Val, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-17888-2_7 · Cited by 6
Nnabue, O. E., Pletcher, S. D., Gurrola, J. G., Goldberg, A. N., Jordan, K. M., Knox, S. M., & May, A. J. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22801 · Cited by 9
Gardner, M., McCarron, A., Morgan, K. S., Parsons, D., & Donnelley, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47465-1 · Cited by 6
A ‘tad’ of hope in the fight against airway disease
Dubaissi, E. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200745 · Cited by 7
Mucking around in the Genome: MUC5B in Idiopathic Pulmonary Fibrosis
Kolb, M. R. J., White, E. S., & Gauldie, J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2360ed · Cited by 6
Potential New Inflammatory Markers in Bronchiectasis: A Literature Review
Bertuccio, F. R., Baio, N., Montini, S., Ferroni, V., Chino, V., Pisanu, L., Russo, M., Giana, I., Cascina, A., Conio, V., et al. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070398 · Cited by 6
“Recent experiments have verified that secreted mucins play a critical role in airway defence [57].”
BackgroundMUC5B Polymorphism in Patients with Idiopathic Pulmonary Fibrosis—Does It Really Matter?
Lewandowska, K. B., Lechowicz, U., Roży, A., Falis, M., Błasińska, K., Jakubowska, L., Franczuk, M., Żołnowska, B., Gryczka-Wróbel, J., Radwan-Röhrenschef, P., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052218 · Cited by 7
“5 and encodes the high molecular weight glycoprotein mucin 5B, which increases the viscosity of mucus gel in the airways [15].”
InfluentialOkada, N., Oshima, K., Maruko, A., & Kobayashi, Y. (2025) · npj Mental Health Research · doi:10.1038/s44184-025-00161-7 · Cited by 8
“In non-responders, genes such as CXCL10 42,43 and MCAM 44 were restored by ketamine, and in responders, genes such as DEFA1B 45 , IL4I1 46 , LRP1 47 , MUC1 48 , MUC5B 49 , MUC6 50 , and C1QTNF3 51 were restored by ketamine.”
The pathobiology and treatment of mucus plugs in asthma and COPD: state of the art
FAHY, J. V. (2026) · European Respiratory Journal · doi:10.1183/13993003.02358-2025 · Cited by 11
Characterizing mucociliary clearance in young children with cystic fibrosis
Laube, B. L., Carson, K. A., Evans, C. M., Aksit, M. A., Collaco, J. M., Richardson, V. L., Sharpless, G., Zeitlin, P. L., Cutting, G. R., & Mogayzel, P. J. (2021) · Pediatric Research · doi:10.1038/s41390-021-01453-2 · Cited by 7
Self-citationCFTR dysfunction leads to defective bacterial eradication on cystic fibrosis airways
Wu, M., & Chen, J.-H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1385661 · Cited by 8
Role of dendritic cells in immunologic and smoking-induced lung diseases
Popper, H. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00141 · Cited by 5
Cerri, S., Manzini, E., Nori, O., Pacchetti, L., Rossi, L., Turchiano, M. G., Samarelli, A. V., Raineri, G., Andrisani, D., Gozzi, F., et al. (2024) · Medicina · doi:10.3390/medicina60121967 · Cited by 8
“This glycoprotein plays a crucial role in mucus production, mucociliary clearance, infection control, and maintaining homeostasis within the airways and lungs [70].”
Kasprzyk, J., Kamińska, A., Mielczarek, P., Piekoszewski, W., Klimkowska, A., Sładek, K., Soja, J., Adamek, D., & Stępień, E. Ł. (2025) · Analytical Methods · doi:10.1039/d4ay01599a · Cited by 5
Alignment free sequence comparison methods and reservoir host prediction
Lee, B., Smith, D. K., & Guan, Y. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab338 · Cited by 7
KCa2 and KCa3.1 Channels in the Airways: A New Therapeutic Target
Orfali, R., AlFaiz, A., Rahman, M. A., Lau, L., Nam, Y.-W., & Zhang, M. (2023) · Biomedicines · doi:10.3390/biomedicines11071780 · Cited by 8
“Mucociliary dysfunction is commonly associated with chronic airway diseases, and it is one of the pathological observations in patients with cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, and asthma [5,6].”
BackgroundHeinzelmann, K., Fysikopoulos, A., Jaquin, T. J., Peper-Gabriel, J. K., Hansbauer, E.-M., Grüner, S., Prassler, J., Wurzenberger, C., Kennedy, J. G. C., Snead, J. Y., et al. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00059.2024 · Cited by 6
Self-citationKarunas, A. S., Yunusbayev, B., Fedorova, Y. Y., Gimalova, G. F., & Хуснутдинова, Э. К. (2015) · Russian Journal of Genetics · doi:10.1134/s1022795415110083 · Cited by 5
“Lung diseases, such as cystic fibrosis, chronic obstructive pulmonary disease, and asthma, are related to mucus hypersecretion, disturbed mucocili ary clearance, and an increased risk of respiratory infections [23].”
BackgroundHuai-Qing, L. O. U., Huang, C., Li, G., Li, P., ZHANG, S.-M., Li, H., Han, L., & Bao, M. (2020) · Iranian Journal of Public Health · doi:10.18502/ijph.v49i12.4801 · Cited by 6
Luo, M., Ni, K., Sun, Y., Guo, J., WEN, K., & Deng, L. (2021) · Biocell · doi:10.32604/biocell.2022.017520 · Cited by 5
Respiratory MUC5B disproportion is involved in severe community-acquired pneumonia
Fan, L., Lü, Y., Wang, Y., Zhang, X., Wu, Y., Sun, H., & Zhang, J. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01870-x · Cited by 5
“By contrast, Muc5AC is the other secreted mucin expressed in airway, but it is not required for MCC or for diminishing infections in the airway [9].”
BackgroundInfluentialMohning, M. P., Downey, G. P., Cosgrove, G. P., & Redente, E. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54431-3.00003-2 · Cited by 123
Fipronil upregulates inflammatory cytokines and MUC5AC expression in human nasal epithelial cells
Kwak, S., Choi, Y. S., Na, H. G., Bae, C. H., Song, S.-Y., & Kim, Y.-D. (2019) · Rhinology Journal · doi:10.4193/rhin19.172 · Cited by 7
The transcriptional landscape of the cultured murine middle ear epithelium in vitro
Mulay, A., Chowdhury, M. M. K., James, C. T., Bingle, L., & Bingle, C. D. (2021) · Biology Open · doi:10.1242/bio.056564 · Cited by 7
“Furthermore, loss of the gel forming mucin, MUC5B has also been shown to cause OM (Roy et al., 2014).”
A big beautiful wall against infection
Jenkins, G. R. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-211220 · Cited by 5
SPDEFending the Lung through Mucin Expression
Evans, C. M., Seibold, M. A., & Gerber, A. N. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0141ed · Cited by 5
“Likewise, Muc5b is the predominant mucin present in healthy mucus secretions of mice, where it is required for innate defense in the upper and lower airways (2).”
BackgroundSelf-citationTOLLIP and MUC5B modulate the effect of ambient NO2 on respiratory symptoms in infancy
Gorlanova, O., Rüttimann, C., Soti, A. L., de Hoogh, K., Vienneau, D., Künstle, N., Sena, C. R. D. S., Steinberg, R., Bovermann, X., Schulzke, S. M., et al. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.142837 · Cited by 5
Structure of the MUC5AC VWD3 assembly responsible for the formation of net-like mucin polymers
Trillo‐Muyo, S., Ermund, A., & Hansson, G. C. (2025) · EMBO Reports · doi:10.1038/s44319-025-00395-8 · Cited by 4
“The MUC5B mucin is required for the normal lung homeostasis in mice whereas the MUC5AC is not (Roy et al, 2014).”
Mechanisms driving immunopathogenesis of viral exacerbations in chronic respiratory disease
McKenzie, J., Carter, C., Jackson, M. M., Singanayagam, A., & Shah, A. (2026) · Thorax · doi:10.1136/thorax-2024-222169 · Cited by 7
“41 42 However, Singanayagam et al showed that although Muc5b was increased during RV-induced exacerbation, Muc5ac was functionally identified as a driver of increased inflammation.”
Wang, J., Shen, X., Li, Y., Xia, Z., Yin, T., Qiao, J., Deng, Y., He, R., Guo, Y., Zhang, Y., et al. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanaf010 · Cited by 5
Tran, T. N. P., & Hung, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06610-z · Cited by 5
“The mucus layer serves as the fi rst line of innate protection in the respiratory tract against inhaled pathogens and particles [38 – 40].”
Limited response of primary nasal epithelial cells to Bordetella pertussis infection
Zmuda, M., Pravdova, B., Malcova, I., Černý, O., Vondrova, D., & Kamanová, J. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01267-25 · Cited by 8
Beghé, B., Fabbri, L. M., Contoli, M., & Papi, A. A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0318up · Cited by 4
“The decrease in MUC5B could alter the mucus gel and impair the immune/inflammatory response (22, 24).”
BackgroundFamilial pulmonary fibrosis - guidelines for diagnostics and treatment
Šterclová, M., Doubek, M., & Doubková, M. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.103 · Cited by 4
Ueda, Y., Mogami, H., Chigusa, Y., KAWAMURA, Y. L., Inohaya, A., Takakura, M., Yasuda, E., Matsuzaka, Y., Shimada, M., Ito, S., et al. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13832 · Cited by 4
Sponchiado, M., Fagan, A., Mata, L., Bonilla, A. L., Trevizan‐Baú, P., Prabhakaran, S., & Reznikov, L. R. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1392443 · Cited by 4
Samarelli, A. V., Tonelli, R., Raineri, G., Bruzzi, G., Andrisani, D., Gozzi, F., Marchioni, A., Costantini, M., Fabbiani, L., Genovese, F., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1275346 · Cited by 5
COPD Update 2015: Zellbiologie goes Clinic? – Wichtige Forschungsergebnisse für den Kliniker
Schmeck, B., Jerrentrup, L., & Bals, R. (2015) · Pneumologie · doi:10.1055/s-0035-1563785 · Cited by 4
Kim, S. Y., Oh, S. H., Lee, J. H., Suh, M., & Park, M. K. (2019) · Stem Cells International · doi:10.1155/2019/4357684 · Cited by 4
“MUC5B is related to mucociliary clearance [20].”
Zhu, J., Yuan, D., Sun, R., Liu, S., & Shan, N. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.08.005 · Cited by 5
Ito, Y., Iwashita, J., Kudoh, A., Kuramata, C., & Murata, J. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2015.1052769 · Cited by 4
Panel 8: Report on Recent Advances in Molecular and Cellular Biochemistry
Preciado, D. A., Granath, A., Lin, J., Val, S., Kurabi, A., Johnston, N., Vijayasekaran, S., Valdez, T. A., Depireux, D. A., & Hermansson, A. (2017) · Otolaryngology · doi:10.1177/0194599816658290 · Cited by 4
“A recent study published in Nature showed that Muc5bnull mice demonstrated a high amount of morbidity in the airways due to severe infection, resulting in systemic infection and ultimately death.(35) An overproduction of Muc5ac was demonstrated by histology techniques in these mice.”
BackgroundTransgenic Mouse Reporter to Study Muc5b In Vivo
Desseyn, J., Portal, C., Gottrand, F., & Gouyer, V. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201802-085aw · Cited by 5
Contribution of ambient airborne particles on the susceptibility to respiratory viral infections
Chivé, C., Martίn-Faivre, L., Michoud, V., Baeza‐Squiban, A., & García-Verdugo, I. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104797 · Cited by 3
Protein Glycosylation: An Emerging Regulator of Allergic Diseases
Li, P., Wang, X., Zeng, M., & Liu, Z. (2025) · Allergy · doi:10.1111/all.70171 · Cited by 5
“Mainly produced by goblet cells, these large glycoproteins play multifaceted roles by providing lubrication, forming a barrier against pathogens and mechanical stress, and facilitating the exchange of gases and nutrients at mucosal surface [91, 92].”
Yao, X. H., Zou, X., & Cao, B. (2025) · Advanced Genetics · doi:10.1002/ggn2.202500022 · Cited by 5
Huang, Y., Su, M., Zhang, Y., pan, J., Wang, Y., Chen, D., Chen, X., Tian, C., Zhang, H., Sun, Q., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69000-3 · Cited by 4
Mechanisms and mediators of disease
Devulder, J. V., & Donnelly, L. (2024) · European Respiratory Society eBooks · doi:10.1183/2312508x.10006423 · Cited by 3
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases
Jiang, S., Desmarais, J., Chu, C., & Zhu, J. (2024) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2024.101945 · Cited by 3
Mucin adhesion of serial cystic fibrosis airways Pseudomonas aeruginosa isolates
Herrmann, C., Lingner, M., Herrmann, S., Brockhausen, I., & Tümmler, B. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1448104 · Cited by 3
“Thanks to the mucociliary escalator, bundles of MUC5B polymers clean the tracheobronchial surface and remove bacteria in healthy airways (Roy et al., 2014; Ermund et al., 2017; 2018b).”
BackgroundGlypican-3 is a key tuner of the Hedgehog pathway in COPD
Petit, L. M. G., Cherif, L. S., Devilliers, M. A., Hatoum, S., Ancel, J., Delépine, G., Durlach, A., Dubernard, X., Mérol, J., Ruaux, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41564 · Cited by 2
Genetic underpinning of idiopathic pulmonary fibrosis: the role of mucin
Kiaei, S. Z. F., & Schwartz, D. A. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2464035 · Cited by 6
“This impaired clearance can result in abnormal bacterial colonization [116,117].”
Self-citationAirway secretory cells contain both a perinuclear Golgi ribbon and dispersed Golgi satellites
Hoang, O. N., Chan, C. S., Brenner, J. M., Leza-Rincon, D., Jaramillo, A. M., Dolan, B., Aziz, A. W., Cardenas, R. A., Cardenas, G. J., Gálvez, E., et al. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag018 · Cited by 3
“The absence of MUC5B in mice and in humans results in impaired mucociliary clearance leading to airway inflammation, infection, and injury (12, 13).”
Self-citationNasal polyposis and asthma: a mechanistic paradigm focusing on Staphylococcus aureus
Bachert, C., Zhang, N., Krysko, O., Crombruggen, K. V., & Gevaert, E. (2017) · European Respiratory Society eBooks · doi:10.1183/2312508x.10010216 · Cited by 3
JiangShi(僵尸): a widely distributed Mucin-like protein essential for Drosophila development
Huang, Y., Li, L., & Rong, Y. S. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac126 · Cited by 3
“On the other hand, there is a limited number of in vivo models for the study of Mucin regulation, with the mouse being the overwhelming choice of model (e.g., Spicer et al. 1995; Velcich et al. 2002; Heazlewood et al. 2008; Roy et al. 2014).”
BackgroundHan, S., Lee, H.-C., Lee, K. C., Kim, D., Kim, J., Kang, D. H., Chung, H.-J., Cha, H., Kim, J., & Song, K. S. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0107 · Cited by 3
“Mucin secretion is essential for lung health, because deletion of Muc5b (mouse mucin 5b) in mice showed a severe loss of mucociliary clearance and accumulation of particulate debris within lung (Roy et al., 2014).”
BackgroundLuo, Y., Wang, H., Zhong, J., Shi, J., Zhang, X., Yang, Y., & Wu, R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21336 · Cited by 4
Genetic Underpinnings of Pulmonary Fibrosis: An Overview
Mahalanobish, S., Ghosh, S., & Sil, P. C. (2024) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257261006231207113809 · Cited by 3
Chen, X., Wang, W., Ye, Y., Yang, Y., Chen, D., He, R., Xiao, Z., Liu, J., Tingting, X., Cai, Y., et al. (2024) · Respiration · doi:10.1159/000536007 · Cited by 3
“The absence of a functional epithelial barrier contributes to reduced mucociliary clearance, rendering the airways more susceptible to microbial invasion and infection [6].”
BackgroundPostow, L., Punturieri, A., Croxton, T. L., Weinmann, G. G., & Kiley, J. P. (2014) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.1.1.2014.0123 · Cited by 3
Poletti, D., Iannini, V., Casolari, P., Contoli, M., Papi, A. A., Kirkham, P., Hansel, T. T., Chung, K. F., Barnes, P. J., Pastore, A. L., et al. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0134-3 · Cited by 3
“The functional role of MUC5AC in the nasal inflammation is still unknown but animal data suggests that this secretory mucin is not involved in the immune defenses of the upper airways [21] despite its potential protective role during influenza infection of the lower airways [22].”
Host–Microbial Interactions: Idiopathic Pulmonary Fibrosis in Technicolor
O’Dwyer, D. N., Habiel, D. M., & Hogaboam, C. M. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0092ed · Cited by 3
Bacteria in Asthma Pathogenesis
Insel, M. B., & Kraft, M. (2019) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2019.03.006 · Cited by 3
Ibudilast Suppresses MUC5AC Mucus Production through Inhibition of ERK1/2 Phosphorylation
Ishibashi, J., Saito, K., Ishizaki, T., Horie, I., & Isohama, Y. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00798 · Cited by 3
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisPreprint
Sakamachi, Y., Wiley, E., Solis, A., Johnson, C. G., Meng, X., Hussain, S., Lipinski, J. H., O’Dwyer, D. N., Randall, T. A., Malphurs, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.30.591719 · Cited by 3
“In mice, muc5b is required for lung microbial clearance ( 30 ), while in IPF patients MUC5B polymorphism is associated with microbial burden ( 6 ), supporting the host immunity-microbiome relationship that we also demonstrate.”
BackgroundSelf-citationDistinct Secretion of MUC5AC and MUC5B in Upper and Lower Chronic Airway Diseases
Shah, S. A., Ishinaga, H., & Takeuchi, K. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.8060 · Cited by 2
“Deletion of the Muc5b gene in mice results in a profound loss of mucociliary clearance, the accumulation of particulate debris in the lung, and a high death rate due to infection or airway obstruction [11].”
BackgroundLiquiritin Suppresses Intracellular and Secreted MUC5AC and MUC5B in Human Airway Epithelial Cells
Yoshio, R., & Iwashita, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168076 · Cited by 3
“MUC5B predominates in the normal respiratory tract and is vital for host defense [4,5].”
Palamà, M. E. F., Gianesin, K., Caracciolo, E., Aiello, M., Scaglione, S., Lucchese, P., & Savarino, V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118609 · Cited by 2
Voetmann, L. M., Rolin, B., Kirk, R. K., Knudsen, L. B., Merkestein, M., Ahnfelt‐Rønne, J., Kodal, A. L. B., Jessen, C., Ozen, A. I., Pyke, C., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70510 · Cited by 3
“20 Cftr and Mucb5 are, therefore, essential mucus secretory factors, 13,14,21 and the Brunner’s glands may be highly relevant for their expression and subsequent mucus secretion.”
An, H., Cheng, X. F., Xue, L., Wang, G., Zhu, X., Li, J., Xiao, T., & Cheng, S. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl41107 · Cited by 3
“MUC5B encodes structurally related mucin glycoproteins [25] and is known to facilitate cell-to-cell and cell-to-matrix interactions, as well as cell-autonomous signaling, thus promoting tumorigenesis and distant dissemination of tumor cells [26].”
Zhao, L., O’Donnell, K. L., Dubey, M., Wang, Y., Martinez, N. R., Zhang, Y., Steininger, H. M., Ma, C., Mallajosyula, V. V. A., Lee, L. L. Y., et al. (2026) · Nature Nanotechnology · doi:10.1038/s41565-025-02107-8 · Cited by 4
Familial interstitial lung disease: emerging insights into screening and genetic risk
Cristancho, A. P. H., Planas‐Cerezales, L., Molina‐Molina, M., Borie, R., Wuyts, W. A., Jodar, M., Sellarés, J., & Hernández‐González, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1747200 · Cited by 4
“It plays a central role in mucus production, mucociliary clearance, host defense, and the maintenance of airway and lung homeostasis (52).”
Research progress on the mechanisms of mucus retention after mycoplasma pneumoniae infection
Li, X., Ma, Y., Cao, S., Wu, W., & Liu, L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1751803 · Cited by 2
“The main mucins in healthy mucus are MUC5B and a small amount of MUC5AC, both of which are crucial for lung homeostasis, host defense, and effective mucus transport (Roy et al., 2014; Livraghi-Butrico et al., 2017; Hancock et al., 2018).”
Airway Mucosal Defense: Mucins, Innate Immunity, and Contemporary Mucoactive Strategies
Akparova, A., Kurmanova, G., Omarova, G., Kurmanova, А., Zhunisbek, M., Bapaeva, M., Zhankina, Z., Sadykova, S. A., Abdrakhmanova, A., & Samadin, A. (2026) · Biomedicines · doi:10.3390/biomedicines14040831 · Cited by 6
“Mice lacking Muc5b develop severe defects in airway defense, including the accumulation of aspirated material, chronic bacterial infections, airway obstruction, and inflammation, indicating that MUC5B plays a central role in maintaining airway sterility and mucus transport mechanisms [44,45].”
Lv, Y., Xiao, Z., Kuang, L., Omindo, W. W., Zhan, X., Tang, W., Liu, X., Wang, X., Fu, L., Zhang, R., et al. (2026) · European journal of medical research · doi:10.1186/s40001-026-04408-7 · Cited by 2
“The symbiotic microbiome can participate in and maintain the composition, expression, and maturation processes of primary respiratory mucins (e.g., mucin 5AC and mucin 5B) [23, 110].”
Song, Y., Wu, X., Tian, H., & Liu, Z. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1777480 · Cited by 2
“Host factors like aging exacerbate these outcomes, as decreased Muc5b production in old mice results in reduced mucociliary clearance, potentially explaining greater viral susceptibility in the elderly (48).”
Goos, T., Verleden, S. E., Sadeleer, L. D., Herck, A. V., Sacreas, A., Vanstapel, A., Kaes, J., Geudens, V., Aelbrecht, C., Ruttens, D., et al. (2022) · Transplant International · doi:10.3389/ti.2022.10159 · Cited by 2
“pre-transplant mortalities in IPF patients with aMUC5Bminor T allele such as an enhanced host defense as a result of increased mucin production involve only the lung as organ system (23).”
BackgroundLu, Y., Zhou, X., Mingming, D., Yin, Y., & Zhou, X. (2023) · International Journal of COPD · doi:10.2147/copd.s419634 · Cited by 3
“written by Roy MG in 2014, mouse Muc5b (but not Muc5ac) was required for mucociliary clearance; a decrease in Muc5b, which is common in most COPD patients, results in apoptotic macrophage accumulation and impaired phagocytosis, leading to chronic infection by multiple bacterial species.(18) In addition to this, the 3r…”
BackgroundThe forecasting power of the mucin-microbiome interplay in livestock respiratory diseases
Mach, N. (2024) · Veterinary Quarterly · doi:10.1080/01652176.2024.2340003 · Cited by 8
“For example, Gram-negative and Gram-positive bacteria, including Pseudomonas aeruginosa and Staphylococcus aureus , induce excessive MUC5B production (Roy et al. 2014; Fan et al. 2022).”
BackgroundLiu, Y., Lv, W., & Wang, W. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08992-6 · Cited by 3
Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant
Tharavecharak, S., Fujimoto, H., Yasuma, T., D’Alessandro‐Gabazza, C. N., Toda, M., Tomaru, A., Saiki, H., Uemura, M., Kogue, Y., Ito, T., et al. (2024) · Cells · doi:10.3390/cells13181523 · Cited by 2
“The research thus offers valuable insights into potential therapeutic strategies that could selectively modulate MUC5B expression to mitigate the progression of fibrotic processes in the lungs.”
Background
Metadata
- Authors
- Roy, M. G., Livraghi-Butrico, A., Fletcher, A. A., McElwee, M. M., Evans, S. E., Boerner, R. M., Alexander, S. N., Bellinghausen, L. K., Song, A. S., Petrova, Y. M., Tuvim, M. J., Adachi, R., Romo, I., Bordt, A. S., Bowden, M. G., Sisson, J. H., Woodruff, P. G., Thornton, D. J., Rousseau, K., De la Garza, M. M., Moghaddam, S. J., Karmouty-Quintana, H., Blackburn, M. R., Drouin, S. M., Davis, C. W., Terrell, K. A., Grubb, B. R., O’Neal, W. K., Flores, S. C., Cota-Gomez, A., Lozupone, C. A., Donnelly, J. M., Watson, A. M., Hennessy, C. E., Keith, R. C., Yang, I. V., Barthel, L., Henson, P. M., Janssen, W. J., Schwartz, D. A., Boucher, R. C., Dickey, B. F., & Evans, C. M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of North Carolina at Chapel Hill (US)
- University of Colorado Anschutz (US)
- The University of Texas Health Science Center at Houston (US)
- Texas A&M Health Science Center (US)
- Nebraska Medical Center (US)
- University of California, San Francisco (US)
- University of Manchester (GB)
- National Jewish Health (US)
- Corresponding author
- Evans, Christopher M.
- ORCID
- Livraghi-Butrico, Alessandra
- Fletcher, Ashley A.
- Evans, Scott E.
- Tuvim, Michael J.
- Adachi, Roberto
- Bordt, Andrea S.
- Bowden, M. Gabriela
- Sisson, Joseph H.
- Woodruff, Prescott G.
- Thornton, David J.
- Moghaddam, Seyed J.
- Blackburn, Michael R.
- Grubb, Barbara R.
- O’Neal, Wanda K.
- Lozupone, Catherine A.
- Watson, Alan M.
- Hennessy, Corinne E.
- Keith, Rebecca C.
- Yang, Ivana V.
- Barthel, Lea
- Henson, Peter M.
- Janssen, William J.
- Schwartz, David A.
- Boucher, Richard C.
- Dickey, Burton F.
- Evans, Christopher M.
- Venue
- Nature
- Published
- 2013-12-08
- Volume
- 505
- Issue
- 7483
- Pages
- 412-416
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4001806
- OpenAlex
- W2008440267
- Cited by
- 764
- References
- 54
- Citations by year
- 2026: 42 · 2025: 41 · 2024: 70 · 2023: 61 · 2022: 76 · 2021: 76 · 2020: 78 · 2019: 58 · 2018: 78 · 2017: 52 · 2016: 53 · 2015: 48 · 2014: 28 · 2013: 2
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA008769)
- National Heart, Lung, and Blood Institute (R01HL097163, R01HL097591, R01HL097000, P01HL110873, P01HL107202, R33HL120770, DP2HL123229, R01HL095372, P50HL107168, P01HL108808, R01HL109517, R01HL117976, R01HL114381, R01HL080396)
- National Cancer Institute (CA 046934, CA 016672, CA016086, P30CA016672, P30CA046934, P30CA016086)
- National Institute of Allergy and Infectious Diseases (U19AI077439)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK090285, P30DK065988)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- MUC5AC, airway mucin, mucociliary clearance, bacterial infection, otitis media, macrophage phagocytosis, IL-23, allergic asthma, chronic obstructive pulmonary disease, Staphylococcus aureus, mucus hypersecretion
- MeSH terms
- Animals, Asthma, Bacterial Infections, Cilia, Ear, Middle, Female, Inflammation, Lung, Macrophages, Male, Mice, Inbred C57BL, Mice, Transgenic, Models, Biological, Phagocytosis, Staphylococcus aureus, Survival Analysis, Respiratory Mucosa, Pulmonary Disease, Chronic Obstructive, Mice, Mucin-5B, Mucin 5AC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.